JESSICA LUJAN: Open Payments
NPI 1750936522 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 63 payments from 18 companies in 2025. Trend: 2023 $244 · 2024 $484 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $410 |
| Corcept Therapeutics | 13 | $165 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| Lilly USA, LLC | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
| Boston Scientific Corporation | 1 | $29 |
Products named: UBRELVY, Korlym, LEQVIO, VOQUEZNA, MOUNJARO, QULIPTA, REXULTI, The Cologuard Plus Collection Kit.
Industry payments across ID — which companies pay providers there.
